BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.500
-0.080 (-3.10%)
At close: Mar 6, 2026, 4:00 PM EST
2.480
-0.020 (-0.80%)
After-hours: Mar 6, 2026, 6:03 PM EST
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $5.91 million as of March 6, 2026. Its market cap has decreased by -3.83% in one year.
Market Cap
5.91M
Enterprise Value
3.25M
1-Year Change
-3.83%
Ranking
Category
Stock Price
$2.50
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $5.91M, a decrease of -85.97%. That is a compound annual growth rate of -30.16%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FutureFuel | 192.30M |
| Core Molding Technologies | 165.32M |
| Aemetis | 92.24M |
| Northern Technologies International | 83.34M |
| 5E Advanced Materials | 81.36M |
| Flexible Solutions International | 68.02M |
| Loop Industries | 63.56M |
| SenesTech | 11.23M |